Announcements
- Arecor and TRx Biosciences research collaboration
- Arecor announces launch of Ogluo® in Netherlands
- Year End Trading Update
- Arecor announces update on INBRX-101
- Arecor granted key European patent
- Expansion of specialty hospital collaboration
- Appointment of SVP for Tetris Pharma Ltd
- Agreement with global medical products company
- Arecor Continues Collaboration with Lilly
- Product with Arestat technology launched in Europe
More ▼
Key statistics
As of last trade Arecor Therapeutics PLC (6UI:FRA) traded at 1.46, 1.39% above its 52-week low of 1.44, set on Apr 17, 2024.
52-week range
Open | 1.45 |
---|---|
High | 1.57 |
Low | 1.45 |
Bid | 1.44 |
Offer | 1.57 |
Previous close | 1.46 |
Average volume | 0.00 |
---|---|
Shares outstanding | 30.63m |
Free float | 14.86m |
P/E (TTM) | -- |
Market cap | 39.36m GBP |
EPS (TTM) | -0.3108 GBP |
Data delayed at least 15 minutes, as of Apr 19 2024 14:29 BST.
More ▼